Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
23,874
Total Value
$570,270.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 7,958 | $21.66 | $172,370.28 | 7,958 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Sale | 7,958 | $50.00 | $397,900.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 7,958 | $0.00 | $0.00 | 87,542 | Direct | โ | View Details |